Artificial Intelligence in Detecting Sacroiliitis Dr. Akhil Sood ( @AkhilSoodMD) discusses Abstract 0383 at #ACR22. https://t.co/U52eAFOePr https://t.co/8WcecoF5Sr

• https://bit.ly/3gCcIqd

Retrospective study looked at 47 adults w/ dermatomyositis treated with tofacitinib. While clinically similar, those on TOFA were were younger (53vs 61), shorter Rx duration (24 vs 53 mos);there was signif CDASI improvement. #ACR22 https://t.co/HrC1GLZQRR https://t.co/yiHsxhpiWe

• https://bit.ly/3H8tmZt

TIME Mag - "Why Masks Still Matter". 1) COVID is still out there; 2) Influenza on the rise. Authors write "With limited yet mixed data, we would be wise to ...err on the side of masking in high risk, indoor crowded public settings..." https://t.co/l8jiTwAdZz https://t.co/0QUKJDOhjs

• https://bit.ly/3gAnOfr

1st quarter of 2022, only 29% of Medicaid and Medicare users had at least one telehealth visit - down from 46% in all of 2021. (Data from Centers for Medicare & Medicaid Services) https://t.co/RCYjlJOPS3

Will a vegetarian diet and exercise actually help RA disease activity? At #ACR22, a Dutch program targeting a whole food plant-based diet, physical activity, and stress management has shown benefit in DAS28 RA disease activity measures. https://t.co/W2axkmbs3y https://t.co/5jktGiEk0T

• https://bit.ly/3GMsqtv

Open label trial compared arthroscopic repair to PT in 100 young pts w/ traumatic, MRI proven meniscal tear without knee OA. Outcomes at 24 months - both groups improvved and were not different between groups https://t.co/rbrUAWuKRa https://t.co/OaNTssAvCG

• https://bit.ly/3XAukTT

Medication adherence is a problem I assume that when I prescribe something for patients that they fill the prescription (right away) and take it as planned…or is this a pipe dream? @Janetbirdope weighs in. https://t.co/qj3insA6fL https://t.co/yV0xlvdNZu

• https://bit.ly/3igkPcu

Does Evusheld shield people living with rheumatic diseases? Dr. Yuz Yusof ( @Yuz6Yusof) discusses three key abstracts from #ACR22 on Evusheld findings. https://t.co/wYl6Wpd5Fs https://t.co/7T7u4czNOX

• https://bit.ly/3V4iO1r

A look back at #ACR22 Day 1. https://t.co/UIZnquWAiU https://t.co/EZ2su56J5H

• https://bit.ly/3APFquw

FDA is investigating risk of severe hypocalcemia in dialysis patients taking Prolia (denosumab). After an interim safety data review reports of hypocalcemia w/ advanced CKD. Monitor Ca, use Ca & vit D supplements. Await further FDA information https://t.co/6pMwBPFJJr https://t.co/lTdpX0FQwj

• https://bit.ly/3F4fu0D

Do oral JAKs in atopic dermatitis cause VTE? Meta-analysis (15 RCTs, 466 993 pts) does NOT show increased risk of VTE associated with AD & JAK inhibitors (HR 0.95) w/ low VTE incidence (0.05%) w/ JAKi and (0.03%) placebo. https://t.co/vcvW8N11cm https://t.co/N5zx0I0lrn

• https://bit.ly/3EINy1b

Where are we with treating Pre-Rheumatoid Arthritis? Dr. Richard Conway ( @RichardPAConway ) discusses abstracts #0530, #1603 and #1604 shared at #ACR22. https://t.co/AagsZCyhSE https://t.co/K1RvdOMzvf

• https://bit.ly/3GOKfIj

Spondyloarthritis Topic Panel - #ACR22 SpA Panelists: Drs. Lianne Gensler, Antoni Chan, Akhil Sood, Eric Dein, Sheila Reyes, Catherine Sims @synovialjoints @AkhilSoodMD @ericdeinmd @RHEUMarampa @DrCassySims https://t.co/uFPW3NxZEm https://t.co/stjmhcFoaS

• https://bit.ly/3U3AOrq

Women vs. Men: Response to Treatment in Seronegative Arthritis Dr. Janet Pope ( @Janetbirdope) discusses abstracts 1614 and 1601 at #ACR22 https://t.co/nUFjPr1Zya https://t.co/L47pzS7YXv

• https://bit.ly/3U3m4sE